Improving success rates for lead generation using affinity binding technologies
- 31 December 2005
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 16 (6) , 666-673
- https://doi.org/10.1016/j.copbio.2005.10.007
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Allosteric Inhibition of PTP1B Activity by Selective Modification of a Non-Active Site Cysteine ResidueBiochemistry, 2005
- A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug designNature Biotechnology, 2005
- Fragment-Based Lead Discovery Using X-ray CrystallographyJournal of Medicinal Chemistry, 2004
- Capillary electrophoretic approach to screen for enzyme inhibitors in natural extracts.2004
- The Evolution of the Matrix Metalloproteinase Inhibitor Drug Discovery Program at Abbott LaboratoriesCurrent Topics in Medicinal Chemistry, 2004
- Discovery of novel inhibitors of Bcl-xL using multiple high-throughput screening platformsAnalytical Biochemistry, 2004
- Ligand efficiency: a useful metric for lead selectionDrug Discovery Today, 2004
- Discovery of Potent Inhibitors of Dihydroneopterin Aldolase Using CrystaLEAD High-Throughput X-ray Crystallographic Screening and Structure-Directed Lead OptimizationJournal of Medicinal Chemistry, 2004
- Fragment Screening and Assembly: A Highly Efficient Approach to a Selective and Cell Active Protein Tyrosine Phosphatase 1B InhibitorJournal of Medicinal Chemistry, 2003
- Frontal affinity chromatography–mass spectrometry assay technology for multiple stages of drug discovery: applications of a chromatographic biosensorAnalytical Biochemistry, 2003